Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Achilles Therapeutics Plc (NQ: ACHL ) 0.8589 +0.0010 (+0.12%) Streaming Delayed Price Updated: 3:31 PM EDT, Jul 17, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Achilles Therapeutics Plc < Previous 1 2 3 Next > 12 Health Care Stocks Moving In Friday's After-Market Session January 06, 2023 Via Benzinga Achilles Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference December 20, 2022 From Achilles Therapeutics PLC Via GlobeNewswire Achilles Therapeutics Presents Encouraging Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma at ESMO IO Congress 2022 December 06, 2022 From Achilles Therapeutics PLC Via GlobeNewswire Why UiPath Shares Are Trading Higher By Around 8%; Here Are 24 Stocks Moving Premarket December 02, 2022 Gainers Via Benzinga Recap: Achilles Therapeutics Q2 Earnings August 09, 2022 Achilles Therapeutics (NASDAQ:ACHL) reported its Q2 earnings results on Tuesday, August 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Via Benzinga Achilles Therapeutics to Present Early Proof of Concept of Safety and Clinical Activity of Clonal Neoantigen Reactive T Cells at the ESMO Immuno-Oncology Annual Congress 2022 November 30, 2022 From Achilles Therapeutics PLC Via GlobeNewswire Achilles Therapeutics Announces Grant of US Patent on Immunotherapies Targeting Clonal Neoantigens Identified Using Proprietary Method November 22, 2022 - US patent is for an immunotherapy targeting clonal neoantigens identified by the Achilles Clonality Engine (ACE), including vaccine, antibody, and autologous T cell therapy approaches - From Achilles Therapeutics PLC Via GlobeNewswire Achilles Therapeutics Reports Third Quarter 2022 Financial Results and Recent Business Highlights November 08, 2022 From Achilles Therapeutics PLC Via GlobeNewswire Achilles Therapeutics: Q1 Earnings Insights May 10, 2022 Achilles Therapeutics (NASDAQ:ACHL) reported its Q1 earnings results on Tuesday, May 10, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Via Benzinga Stocks That Hit 52-Week Lows On Friday February 04, 2022 On Friday, 209 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Meta Platforms (NASDAQ:FB) was the largest firm on a market cap... Via Benzinga Achilles Therapeutics Co-founder Professor Charles Swanton to Participate in Expert Roundtable Highlighting Pivotal Nature of Neoantigens as Targets in Cancer Cell Therapy October 06, 2022 From Achilles Therapeutics PLC Via GlobeNewswire 5 Value Stocks To Watch In The Healthcare Sector August 08, 2022 The Meaning Behind Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base... Via Benzinga 5 Value Stocks In The Healthcare Sector August 01, 2022 What is a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators... Via Benzinga Tesla, Coinbase Global And 41 Stocks Moving In Monday's Mid-Day Session July 18, 2022 Gainers Intelligent Living Application Group Inc. (NASDAQ: ILAG) shares jumped 90.2% to $4.2792 after declining 11% on Friday. The company reported closing of $20.24 million initial public offering. Via Benzinga Why Qudian Shares Jumped Over 40%; Here Are 73 Biggest Movers From Yesterday July 19, 2022 Gainers AMTD Digital Inc. (NYSE: HKD) climbed 71.5% to close at $27.80 on Monday after gaining 108% on Friday. The company priced its IPO at $7 per share. Via Benzinga Why U.S. Stocks Are Trading Higher; Goldman Sachs Tops Q2 Views July 18, 2022 U.S. stocks traded higher this morning, following earnings results from big banks. Via Benzinga 5 Value Stocks To Watch In The Healthcare Sector June 27, 2022 What Defines a Value Stock? Via Benzinga Achilles Therapeutics Doses First Patient with Higher-dose cNeT in CHIRON Phase 1/2a Trial for Advanced NSCLC May 09, 2022 Achilles Therapeutics plc (NASDAQ: ACHL) announced that the first patient has been dosed with personalized clonal neoantigen-reactive T cells, or cNeT, manufactured with the Company's higher-dose... Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session May 02, 2022 Gainers Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session April 19, 2022 Gainers Via Benzinga Secarna Pharmaceuticals and Achilles Therapeutics Sign Research, Option and License Agreement to Develop Optimized T Cell Therapies November 10, 2021 - Secarna's LNAplusTM ASOs have the potential to optimize personalized T cell therapies being developed by Achilles - Secarna's industry-leading antisense oligonucleotide (ASO) platform LNAplusTM... From Secarna Pharmaceuticals GmbH & Co. KG Via AccessWire 51 Biggest Movers From Yesterday October 01, 2021 Gainers Superior Drilling Products, Inc. (NYSE: SDPI) shares rose 60.6% to close at $1.75 on Thursday after jumping over 23% on Wednesday. The company, last month, reported Q2... Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session September 27, 2021 Gainers Syndax Pharmaceuticals (NASDAQ:SNDX) shares moved upwards by 8.94% to $20.48 during Monday's pre-market session. The company's market cap stands at $995.9... Via Benzinga 48 Biggest Movers From Friday September 27, 2021 Gainers ZIVO Bioscience, Inc. (NASDAQ: ZIVO) shares climbed 58% to close at $5.45 on Friday. Clearwater Analytics Holdings, Inc. (NYSE: CWAN) surged 40.9% to settle at $25.37... Via Benzinga The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study September 16, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 15) Alcon Inc. (NYSE: ALC)... Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session September 10, 2021 Gainers IVERIC bio (NASDAQ:ISEE) stock increased by 65.36% to $14.37 during Friday's pre-market session. The company's market cap stands at $1.4 billion. T2... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session September 08, 2021 Gainers Kadmon Holdings (NASDAQ:KDMN) shares rose 73.39% to $9.19 during Wednesday's pre-market session. The market value of their outstanding shares is at $1.5... Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session August 12, 2021 Gainers NanoVibronix (NASDAQ:NAOV) stock increased by 23.8% to $2.86 during Thursday's regular session. As of 12:30 EST, this security is trading at a volume of 65.6... Via Benzinga The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO August 13, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 12) Adagio Therapeutics, Inc. (... Via Benzinga Exposures Product Safety 66 Biggest Movers From Yesterday August 12, 2021 Gainers Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) shares jumped 50.5% to close at $20.74 on Wednesday. The company, last month, priced its IPO at $11 per share. Dyadic... Via Benzinga Topics Initial Public Offering Exposures Securities Market < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.